Barlogie B - Search Results

1

Intensive combination chemotherapy (ROAP 10) and splenectomy in the management of chronic myelogenous leukemia.

Kantarjian HM, Vellekoop L, McCredie KB, Keating MJ, Hester J, Smith T, Barlogie B, Trujillo J, Freireich EJ. Kantarjian HM, et al. Among authors: barlogie b. J Clin Oncol. 1985 Feb;3(2):192-200. doi: 10.1200/JCO.1985.3.2.192. J Clin Oncol. 1985. PMID: 3855444

2

Results of the vincristine, doxorubicin, and dexamethasone regimen in adults with standard- and high-risk acute lymphocytic leukemia.

Kantarjian HM, Walters RS, Keating MJ, Smith TL, O'Brien S, Estey EH, Huh YO, Spinolo J, Dicke K, Barlogie B, et al. Kantarjian HM, et al. Among authors: barlogie b. J Clin Oncol. 1990 Jun;8(6):994-1004. doi: 10.1200/JCO.1990.8.6.994. J Clin Oncol. 1990. PMID: 2189958 Clinical Trial.

3

Fludarabine: a new agent with major activity against chronic lymphocytic leukemia.

Keating MJ, Kantarjian H, Talpaz M, Redman J, Koller C, Barlogie B, Velasquez W, Plunkett W, Freireich EJ, McCredie KB. Keating MJ, et al. Among authors: barlogie b. Blood. 1989 Jul;74(1):19-25. Blood. 1989. PMID: 2473795 Free article.

4

Experience with vincristine, doxorubicin, and dexamethasone (VAD) chemotherapy in adults with refractory acute lymphocytic leukemia.

Kantarjian HM, Walters RS, Keating MJ, Barlogie B, McCredie KB, Freireich EJ. Kantarjian HM, et al. Among authors: barlogie b. Cancer. 1989 Jul 1;64(1):16-22. doi: 10.1002/1097-0142(19890701)64:1<16::aid-cncr2820640104>3.0.co;2-o. Cancer. 1989. PMID: 2659160

5

Pretreatment of cytokinetics in acute myelogenous leukemia. Age-related prognostic implications.

Kantarjian HM, Barlogie B, Keating MJ, Hall RR, Smith TL, McCredie KB, Freireich EJ. Kantarjian HM, et al. Among authors: barlogie b. J Clin Invest. 1985 Jul;76(1):319-24. doi: 10.1172/JCI111964. J Clin Invest. 1985. PMID: 3860508 Free PMC article.

6

DNA-RNA measurements in patients with acute leukemia undergoing remission induction therapy.

Maddox AM, Johnston DA, Barlogie B, Youness E, Keating M, Freireich EJ. Maddox AM, et al. Among authors: barlogie b. J Clin Oncol. 1985 Jun;3(6):799-808. doi: 10.1200/JCO.1985.3.6.799. J Clin Oncol. 1985. PMID: 4009216

7

High-dose cytosine arabinoside in non-Hodgkin's lymphoma.

Kantarjian H, Barlogie B, Plunkett W, Velasquez W, McLaughlin P, Riggs S, Cabanillas F. Kantarjian H, et al. Among authors: barlogie b. J Clin Oncol. 1983 Nov;1(11):689-94. doi: 10.1200/JCO.1983.1.11.689. J Clin Oncol. 1983. PMID: 6366130

8

In vitro suppression of DNA synthesis by a remission induction agent and its correlation with response in adult acute leukemia.

Maddox AM, Johnston DA, Barlogie B, Haq M, Keating MJ, Freireich EJ. Maddox AM, et al. Among authors: barlogie b. Eur J Cancer Clin Oncol. 1984 Apr;20(4):507-14. doi: 10.1016/0277-5379(84)90237-2. Eur J Cancer Clin Oncol. 1984. PMID: 6586421

9

Identification of risk groups for development of central nervous system leukemia in adults with acute lymphocytic leukemia.

Kantarjian HM, Walters RS, Smith TL, Keating MJ, Barlogie B, McCredie KB, Freireich EJ. Kantarjian HM, et al. Among authors: barlogie b. Blood. 1988 Nov;72(5):1784-9. Blood. 1988. PMID: 3052630 Free article.

10

The hematologic malignancies. Leukemia, lymphoma, and myeloma.

Freireich EJ, Keating M, Cabanillas F, Barlogie B. Freireich EJ, et al. Among authors: barlogie b. Cancer. 1984 Dec 1;54(11 Suppl):2741-50. doi: 10.1002/1097-0142(19841201)54:2+<2741::aid-cncr2820541422>3.0.co;2-9. Cancer. 1984. PMID: 6208991 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

696 results

Search Page

Filters